---
title: "Telaprevir - Chronic hepatitis c"
sidebar: mydoc_sidebar
permalink: db05521-mesh-d019698-1.html
toc: false 
---


Path ID: `DB05521_MESH_D019698_1`
{% include image.html url="images/db05521-mesh-d019698-1.png" file="db05521-mesh-d019698-1.png" alt="db05521-mesh-d019698-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:C486464 | Telaprevir | Drug |
| UniProt:B0B3C9 | Genome polyprotein | Protein |
| GO:0039694 | Viral RNA genome replication | BiologicalProcess |
| GO:0008236 | Serine-type peptidase activity | MolecularActivity |
| NCBITaxon:11103 | Hepacivirus C | OrganismTaxon |
| MESH:D019698 | Chronic hepatitis C | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Telaprevir | DECREASES ACTIVITY OF | Genome Polyprotein |
| Genome Polyprotein | POSITIVELY REGULATES | Viral Rna Genome Replication |
| Genome Polyprotein | CAPABLE OF | Serine-Type Peptidase Activity |
| Viral Rna Genome Replication | IN TAXON | Hepacivirus C |
| Serine-Type Peptidase Activity | IN TAXON | Hepacivirus C |
| Hepacivirus C | CAUSES | Chronic Hepatitis C |
|---------|-----------|---------|

Comment: Withdrawn

Reference: [https://go.drugbank.com/drugs/DB05521#mechanism-of-action](https://go.drugbank.com/drugs/DB05521#mechanism-of-action){:target="_blank"}